Ozempic and surgery: When to stop and restart treatment
If you take Ozempic and have surgery coming up, one conversation with your anesthesiologist before the procedure can eliminate the main risk the medication creates and it starts with telling them you're on it.
Key highlights
- Ozempic is a popular GLP-1 receptor agonist used to manage type 2 diabetes, reduce cardiovascular risk, and lower the risk of kidney failure in patients with chronic kidney disease. The medication is also used off-label to promote weight loss.
- Like other GLP-1 medications, Ozempic delays gastric emptying, which can increase the risk of aspiration during anesthesia and sedation, even if the patient has been fasting for the recommended timeline.
- The American Society of Anesthesiologists (ASA) recommends stopping injectable GLP-1 medications 7 days before surgery and oral medications on the day of surgery.
- Updated 2024 ASA guidance introduces an alternative approach: a 24-hour clear liquid diet before surgery combined with a point-of-care gastric ultrasound, rather than stopping the medication.
- In case of emergency surgery, your medical team may take additional precautions, such as rapid sequence intubation (RSI) and a gastric ultrasound, to reduce the risk of aspiration and ensure patient safety.
- There is no universal timeline for restarting Ozempic after surgery. It depends on the nature of the procedure, the patient's recovery, and the clinician's decision. You can restart Ozempic once you start eating and drinking normally and have no gastrointestinal side effects.
You have packed your hospital bag, arranged time off work, and you are ready for your upcoming surgery, but there’s one thing in your medicine cabinet that could cancel your operation or put you at serious risk: your Ozempic pen.
Glucagon-like peptide-1 receptor agonists, such as semaglutide (Ozempic, Wegovy, and Rybelsus), have recently gained popularity for treating type 2 diabetes and promoting weight loss. Ozempic is FDA-approved for treating type 2 diabetes, lowering the risk of worsening kidney disease in patients with chronic kidney disease, and reducing cardiovascular risk. It is used off-label for weight management.
Like other weight loss medications, Ozempic has both pros and cons. In June 2023, the American Society of Anesthesiologists (ASA) issued consensus-based guidance warning that GLP-1 drugs can delay gastric emptying and may increase the risk of regurgitation and pulmonary aspiration (stomach contents entering the respiratory system) during anesthesia. These drugs slow gastric emptying as part of their mechanism of action, which helps control appetite and blood glucose. It keeps food in the stomach far longer than expected, requiring a total rethink of “pre-op” prep. This article explains exactly how Ozempic interacts with surgery, how long you need to be off it, and when it is safe to restart the medication.
The risks of mixing Ozempic and anesthesia
Ozempic works by slowing gastric emptying, which delays digestion and relaxes the stomach muscles, slowing the movement of food from the stomach into the small intestine. Delayed stomach emptying gives a feeling of fullness or satiety, reduces food intake by suppressing appetite, and promotes weight loss and blood sugar control. This mechanism of action can lead to a serious problem during sedation and anesthesia.
If you are taking Ozempic, you may still have residual stomach contents despite being fully compliant with fasting due to delayed gastric emptying. Residual stomach content can cause pulmonary aspiration (stomach contents entering the lungs) during intubation.
A 2024 cross-sectional study of 124 patients published in the JAMA Surgery shows that patients using GLP-1 receptors have a higher prevalence of residual gastric content due to delayed gastric emptying. According to this study, 124 patients undergoing elective procedures under anesthesia followed fasting guidelines. The prevalence of residual gastric contents was assessed using ultrasonography. Approximately 56% of GLP-1 receptor agonist users had increased residual gastric content despite fasting, compared with 19% of nonusers.
Understanding gastroparesis
GLP-1 receptor agonists such as semaglutide mimic the activity of the GLP-1 hormone and slow stomach motility, which means meals may remain in the stomach longer than expected. Delayed gastric emptying makes you feel full longer, which is great for weight loss, but dangerous for surgery.
The risk of pulmonary aspiration
According to preoperative fasting guidelines, solid food clears from the stomach within approximately 6 hours in most healthy individuals. That is why patients are instructed to remain “nil per os” (NPO) after midnight or for a defined fasting window before surgery.
Ozempic slows gastric motility as part of its therapeutic effect. While this effect is beneficial for promoting satiety and glycemic control, this delay keeps food and liquid in the stomach far longer than expected, even beyond standard fasting periods. When patients are on GLP-1 medications like Ozempic, they may have residual gastric contents despite staying NPO (nil per os), which can cause pulmonary aspiration.
Pulmonary aspiration occurs when gastric contents ascend into the esophagus and enter the lungs during anesthesia or sedation. Normally, food does not enter the lungs due to protective airway reflexes such as coughing and swallowing. When you are under general anesthesia, these reflexes are suppressed, and stomach contents can enter the lungs. Pulmonary aspiration can cause chemical pneumonitis, aspiration pneumonia, and airway obstruction or acute respiratory distress, which can be life-threatening.
Official guidelines: When to stop Ozempic before surgery
Here are the official guidelines about when to stop Ozempic before surgery:
The American Society of Anesthesiologists (ASA) guidelines
The American Society of Anesthesiologists (ASA) issued consensus-based guidelines for the perioperative management of oral and injectable GLP-1 receptor agonists.
For weekly injections (Ozempic, Wegovy, Mounjaro)
The ASA recommends that if a patient is receiving weekly injections (Ozempic, Wegovy, or Mounjaro), the medication be discontinued 7 days before elective surgery. If they are on daily pills (Rybelsus and Wegovy pills), they should hold the medication on the day of the procedure.
These guidelines are irrespective of the indication (type 2 diabetes mellitus or weight management), dose of the medication, or the type of procedure or surgery. Additionally, if you are using Ozempic for diabetes management and are held for longer than the dosing schedule, consult with your healthcare provider to bridge the antidiabetic therapy to avoid hyperglycemia.
The “symptoms matter” rule
These guidelines also recommend that if the patient has nausea, vomiting, abdominal pain, or bloating, the surgery or procedure should be delayed regardless of whether the medication has been withheld according to recommended guidelines or continued.
Liquid diet alternatives
The American Society of Anesthesiologists updated guidelines for anesthesia in patients using GLP-1 medications in October 2024. These guidelines introduce practical alternatives to stopping the medication. According to updated guidelines, patients should stay on a clear liquid diet 24 hours before surgery instead of discontinuing the GLP-1 drug, and the medical team should perform an ultrasound before surgery to assess stomach contents in high-risk patients.
This approach aims to minimize the risk of aspiration and allows patients to continue their medication. It is particularly helpful when discontinuing the medication can lead to hyperglycemia and negatively affect metabolic control.
What about the liquid diet phase?
Even if your healthcare provider has recommended a preoperative liquid diet (commonly used in bariatric surgery to reduce gastric contents), the risk of aspiration associated with Ozempic does not disappear entirely. Ozempic slows gastric emptying regardless of whether you are taking solids or liquids. However, you may still have residual gastric contents despite adhering to a fasting or liquid-only diet. A liquid-only diet does not guarantee an empty stomach at the time of surgery. The same guidelines emphasize that even if the patient is following a clear liquid diet, clinicians should base their decision on the patient’s symptoms or assess stomach contents with ultrasound.
A 24-hour clear liquid diet can be used as a risk-reduction strategy, but it can not be considered a substitute for clinical judgment or a guarantee against aspiration risk.
Do you need a gastric ultrasound?
As discussed earlier, patients using GLP-1 receptor agonists may have residual gastric contents despite fasting or following a 24-hour liquid diet. Some anesthesiologists use point-of-care gastric ultrasound immediately before surgery to assess whether the stomach is empty, which is especially useful in patients taking medications like semaglutide that can delay gastric emptying.
The 2024 guidelines by the American Society of Anesthesiologists specifically recommend that a gastric ultrasound should be used to evaluate stomach contents when there are concerns about delayed emptying or aspiration risk.
If the ultrasound suggests that the stomach still contains residual contents, the anesthesia team may decide to delay or reschedule the procedure. If you are going for surgery and your doctor performs a gastric ultrasound, there is nothing to worry about. It is a proactive measure to reduce the risk of aspiration and its complications.
Bariatric surgery and Ozempic
Bariatric surgery and Ozempic (off-label) are both used for weight management in obese and overweight patients. However, long-term evidence demonstrates that bariatric surgery is a more durable intervention for many patients with obesity and type 2 diabetes than Ozempic.
Long-term health benefits
A Cleveland Clinic study published in Nature Medicine compared 1,657 patients who underwent metabolic surgery with 2,275 patients treated with GLP-1 receptor agonists. This study found that bariatric surgery was associated with lower risks of all-cause mortality (9.0% in the surgery group and 12.4% in the GLP-1 group), major cardiovascular events, nephropathy, and retinopathy over long-term follow-up. This study concludes that weight-loss or bariatric surgery has greater long-term benefits than GLP-1 medicines alone.
The hybrid approach
Ozempic can be used alongside bariatric surgery. Bariatric teams use GLP-1 medications before surgery to help patients lower their body mass index, improve blood sugar control, and reduce operative risk. Additionally, Ozempic is used after surgery to maintain weight loss or prevent weight regain. Ozempic and bariatric surgery are used as a hybrid approach in which surgery provides the strongest long-term metabolic intervention, while GLP-1 therapy supports patients before and after the operation.
The “escalation phase”
The highest-risk timing is the early “escalation phase,” when Ozempic is started or the dose is increased. The 2024 multi-society guidance states that patients are more likely to have delayed gastric emptying during dose escalation. Scheduling surgery during this window is risky because patients have a higher risk of nausea, bloating, vomiting, constipation, or early fullness, and delayed gastric emptying during this phase. They may have residual gastric contents, which increases the risk of aspiration during anesthesia.
These guidelines recommend that elective surgery should be deferred until the escalation phase has passed and gastrointestinal side effects have resolved. The escalation phase typically lasts for 4-8 weeks, depending on the prescribed titration schedule and individual tolerance, and the elective surgery should be scheduled after this phase.
Pre-bariatric surgery: The liver shrink diet conflict
Many healthcare professionals prescribe Ozempic for obese patients before bariatric surgery to initiate weight loss before their procedure. This approach can improve metabolic health, reduce body weight, and help shrink fatty liver tissue before surgery, which may make the operation safer and easier for the surgeon.
However, this creates a clinical paradox. Although Ozempic helps patients become better surgical candidates, it can also complicate anesthesia because the medication delays gastric emptying and increases the risk of residual stomach contents.
For this reason, if you are taking Ozempic before your bariatric surgery, follow preoperative instructions carefully. Stop the injectable medication 7 days before surgery, or shift to a liquid diet 24 hours before surgery, as recommended by your healthcare professional. If you still experience any side effects of the medication, such as bloating, abdominal discomfort, nausea, or vomiting before surgery, immediately report these symptoms to your doctor. They may delay or reschedule your surgery.
Safe perioperative management depends on clear communication among the bariatric surgeon, prescribing physician, and anesthesiologist to ensure your weight-loss goals do not compromise anesthesia safety.
Ozempic as an adjunct after weight loss surgery
Healthcare providers recommend Ozempic for patients who experience weight regain or continue to struggle with type 2 diabetes after procedures such as sleeve gastrectomy or gastric bypass. Although bariatric surgery is one of the most effective long-term treatments for obesity, some patients gradually regain weight over time because obesity is a chronic metabolic disease, and surgery alone cannot fix it.
Recent clinical studies show that GLP-1 receptor agonists, including semaglutide, can be used to achieve additional weight loss and improve glycemic control in post-bariatric patients with inadequate response or recurrent metabolic disease after surgery.
As bariatric surgery significantly alters gastrointestinal anatomy and physiology, the medications may act differently after surgery. Bariatric procedures such as Roux-en-Y gastric bypass and sleeve gastrectomy alter gastric volume, intestinal transit, nutrient absorption, and hormone signaling. These changes alter your body’s tolerance to the medications. Ozempic slows gastric emptying, and postoperative patients may be more vulnerable to gastrointestinal side effects such as nausea, vomiting, abdominal pain, dehydration, or poor oral intake, especially during dose escalation.
For this reason, clinicians typically recommend close monitoring when semaglutide is introduced after bariatric surgery. Patients may require slower dose titration, dietary modifications, and careful assessment of hydration status to ensure that the medication supports metabolic recovery without worsening postoperative gastrointestinal symptoms.
Plastic surgery and “Ozempic face”
Since Ozempic and other GLP-1 receptor agonists have gained popularity, there has been a rapid surge in demand for aesthetic and reconstructive procedures. When patients lose body weight rapidly over a relatively short period, they are more prone to facial volume loss, skin laxity, and excess tissue around the abdomen, arms, thighs, and neck. The phenomenon “Ozempic face” is not caused by the drug itself but by rapid fat loss that reduces subcutaneous facial volume and leads to skin laxity. Most patients are choosing plastic surgery procedures such as facelifts, neck lifts, body contouring, and post-weight-loss skin removal after using Ozempic.
However, these patients present with certain surgical challenges. Rapid weight loss can affect nutritional status, muscle mass, hydration, and skin quality, which are essential for wound healing and surgical recovery. Massive weight loss can increase the risk of nutritional deficiencies, including protein, iron, vitamin B12, folate, and fat-soluble vitamins, particularly in patients who have also undergone bariatric surgery. Additionally, significant weight fluctuations may reduce skin elasticity, complicate the prediction of surgical outcomes, and increase the risk of recurrent skin laxity after plastic surgery.
Most plastic surgeons recommend that patients achieve a stable weight before opting for any skin-removal or contouring surgery. Patients should wait for approximately 3-6 months before surgery to stabilize their body weight before undergoing any plastic surgery for better cosmetic outcomes.
Emergency surgery: What if you can’t stop Ozempic in time?
Emergency surgeries are always unplanned. For instance, if you break a leg, develop appendicitis, or require another emergency operation, there may not be enough time to stop Ozempic 7 days before anesthesia or shift to a 24-hour liquid-only diet. In these situations, your anesthetists will take extra precautions to prevent the risk of aspiration.
- Inform the medical team (emergency physician, anesthesiologist, and surgeon) as soon as you are admitted to the hospital that you are taking Ozempic. They will take extra precautions to reduce the risk of aspiration.
- Even if you have not eaten recently, anesthesia teams may treat you as a “full stomach” patient and assume that food or liquid is still present in the stomach because semaglutide delays gastric emptying.
- Your anesthesiologists may perform a technique called Rapid Sequence Intubation (RSI), which secures the airway quickly after induction of anesthesia to reduce the chance of stomach contents entering the lungs. RSI is commonly used for patients who are at risk of aspiration.
- Your clinician may also use a bedside gastric ultrasound to evaluate stomach contents before surgery.
These precautions are not meant to alarm patients or delay necessary care. Emergency anesthesia teams are trained to manage high-risk airways every day. The purpose of these protocols is to make surgery safer.
When can you resume Ozempic after surgery?
There is no universal timeline to restart Ozempic after surgery. It depends on the nature of the surgery and the patient’s recovery.
Post-operative gut function (Ileus)
Surgery can temporarily slow gastrointestinal function, a condition known as postoperative ileus. During ileus, the intestines move more slowly than normal, which can delay digestion and cause bloating, nausea, abdominal discomfort, and constipation. Additionally, clinicians commonly administer opioids for pain management, which can also worsen this effect by further reducing bowel motility.
As GLP-1 receptor agonists like Ozempic also slow gastric emptying, restarting Ozempic too early after surgery may lead to postoperative gut dysfunction. This can increase the risk of severe nausea, vomiting, dehydration, delayed recovery of bowel function, and may cause bowel obstruction.
General timeline for restarting:
Clinicians may recommend that patients wait until they can eat and drink normally, tolerate food without nausea or vomiting, and have passed gas or had a bowel movement before restarting Ozempic. All of these indicators show that gastrointestinal motility has recovered appropriately after surgery.
If you had a minor procedure, you may restart the medication after approximately 2–4 days. In contrast, if you had a major abdominal or gastrointestinal surgery, you may need to wait 1-2 weeks or longer, depending on the nature of your surgery and the speed of bowel recovery.
There is currently no universal postoperative timeline endorsed by all surgical societies. Clinicians make the decisions based on the patient’s recovery, nutritional status, diabetes control, and the type of procedure. Never restart Ozempic independently after surgery. Always consult your surgeon to discuss when you can start the medication safely without interfering with postoperative recovery.
What to ask your doctor
You should discuss the following concerns with your doctor:
- Tell every doctor involved (surgeon, anesthesiologist, and emergency physician) that you take Ozempic or any other GLP-1 medication.
- Stop weekly injections 7 days before surgery. If you are taking daily oral pills or injections, skip the dose on the day of surgery.
- Follow your fasting instructions strictly, but know that your stomach may still not be empty. If your doctor recommends a 24-hour liquid diet, take liquids only.
- In case of any emergency surgery, inform your attending physician, anesthesiologist, and surgeons about the medication immediately.
- When you have undergone surgery, wait for your surgeon’s “all clear” message and signs of normal digestion before injecting again.
- You should ask the following questions when planning a surgery:
- Should I follow a 24-hour liquid diet?
- Will you use a gastric ultrasound on the day of surgery?
- How do we manage my blood sugar if I’m diabetic and holding the dose?
FAQs
Can I take my Ozempic the day before surgery if I’m just having a local anesthetic?
Local anesthesia is usually safe. It typically does not require an NPO (nil per os) protocol. However, if your procedure needs sedation or general anesthesia, you have to stop the medication 7 days before surgery or shift to a 24-hour liquid diet, as advised by your clinician. If you are going to have a local anesthetic, verify with your provider whether you can inject Ozempic.
Will stopping Ozempic for a week spike my blood sugar?
Yes, stopping Ozempic might cause blood sugar spikes. Your surgical team will monitor your blood sugar levels in the hospital and may use fast-acting insulin to manage them during the procedure. It is safer to have high blood sugar for a day than to aspirate.
My doctor never told me to stop. What should I do?
If your doctor did not tell you to stop Ozempic, call their office immediately. If your surgery is tomorrow and you have taken Ozempic recently, tell the anesthesiologist as soon as you arrive at the hospital. They will either take precautionary measures to prevent aspiration or reschedule your surgery. They may perform a gastric ultrasound to check residual gastric contents.
What if it’s an emergency surgery?
In case of emergency surgery while taking Ozempic, your anesthesiologists will take standard “full stomach” precautions to reduce the risk of aspiration. They may perform a gastric ultrasound to check residual gastric contents and use an anesthesia technique called Rapid Sequence Intubation (RSI) to prevent aspiration.
When can I restart Ozempic after surgery?
You can restart Ozempic once you have resumed eating solid foods after surgery, are eating and drinking normally, and your gastrointestinal symptoms have resolved. It typically takes 1-2 days to restart Ozempic after minor surgeries. However, if you had major surgery, you may have to wait for 1-2 weeks or longer. Never restart the medication on your own. Consult your surgeon and clinician to ensure Ozempic is safe to restart.
Does Ozempic affect wound healing?
Ozempic does not directly affect wound healing, but rapid weight loss and reduced calorie intake can contribute to poor nutrition, which may slow recovery after surgery. Nutritional deficiencies in protein, iron, zinc, and vitamin B12 can negatively affect or delay healing.
Conclusion: Understanding when to stop and restart Ozempic
Although Ozempic and other GLP-1 receptor agonists have transformed the treatment of obesity and type 2 diabetes, they can increase the risk of aspiration during anesthesia and surgery due to delayed gastric emptying. The good news is that this risk is manageable with proper planning.
The benefits of Ozempic outweigh the slight inconvenience of temporarily adjusting Ozempic treatment before your procedure. Your doctor may recommend holding injectable GLP-1 medications (Ozempic) for 7 days before surgery and oral pills on the day of surgery. Additionally, your clinician may also recommend switching to a 24-hour liquid diet before surgery instead of holding the medication for 7 days. In case of emergency surgery, they may perform rapid sequence intubation (RSI) to prevent aspiration.
If you have an upcoming procedure, do not wait until the day before surgery to ask questions. Call your surgeon’s office and discuss your concerns as early as possible. A 5-minute conversation can save you from the risk of complications. When deciding whether to stop or restart Ozempic, always involve your entire medical team, including your primary care physician, surgeon, and anesthesiologist, to ensure safety and prevent serious complications.
